19.6: Key Words and Terms
| anaphase | G 2 phase | mTOR signaling |
| apoptosis | Guardian of the Genome | necrosis |
| ATM kinase | immunotherapy | oncogenic viruses |
| benign tumors | intergrin | p14ARF |
| cancer cells | interphase | p21 |
| CDKs | invasive tumors | p53 |
| cell cycle | LFS | |
| cell cycle checkpoints | Li-Fraumeni Syndrome | PD-L1 |
| chemotherapy | M checkpoint | programmed cell death |
| Chk2 | M phase of the cell cycle | prophase |
| colchicine | malignant tumors | protein phosphorlyation |
| cyclin | MAPK | proteasome |
| cyclin level in cell cycle | maturation | radiation therapy |
| cytokinesis | maturation promoting | S phase |
| dideoxyNTP | Mdm2 | signal transduction |
| elephant p53 genes | metaphase | SV40 |
| FAK | metastasis | T antigens |
| G 0 of the cell cycle | mitosis | taxol |
| G 1 checkpoint | mitosis promoting factor | telophase |
| G 1 phase | mitotic phases | tumor suppressor protein |
| G 2 checkpoint | MPF | ubiquitination |